Jpmorgan Chase & CO Stevanato Group S.P.A. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 505 shares of STVN stock, worth $11,216. This represents 0.0% of its overall portfolio holdings.
Number of Shares
505
Previous 606
16.67%
Holding current value
$11,216
Previous $13,000
23.08%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding STVN
# of Institutions
146Shares Held
53.7MCall Options Held
2KPut Options Held
1K-
Conestoga Capital Advisors, LLC8.19MShares$182 Million2.52% of portfolio
-
Neuberger Berman Group LLC New York, NY4.6MShares$102 Million0.08% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.74MShares$83.2 Million0.05% of portfolio
-
Times Square Capital Management, LLC3.36MShares$74.6 Million1.18% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.28MShares$50.6 Million0.08% of portfolio
About Stevanato Group S.p.A.
- Ticker STVN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 264,700,000
- Market Cap $5.88B
- Description
- Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...